Phase 3 trial of [177Lu]Lu-PSMA-617 in taxane-naive patients with metastatic castration-resistant prostate cancer (PSMAfore) Meeting Abstract

  


Authors: Herrmann, K.; Sartor, O.; Castellano, D.; de Bono, J.; Shore, N.; Chi, K.; Crosby, M.; Piulats, J.; Flechon, A.; Wei, X.; Mahammedi, H.; Roubaud, G.; Študentová, H.; Ghebremariam, S.; Kpamegan, E.; Kreisl, T.; Delgoshaie, N.; Lehnhoff, K.; Morris, M.; Fizazi, K.
Abstract Title: Phase 3 trial of [177Lu]Lu-PSMA-617 in taxane-naive patients with metastatic castration-resistant prostate cancer (PSMAfore)
Meeting Title: 2024 SNMMI Annual Meeting
Journal Title: Journal of Nuclear Medicine
Volume: 65
Issue: Suppl. 2
Meeting Dates: 2024 Jun 8-11
Meeting Location: Toronto, Canada
ISSN: 0161-5505
Publisher: Society of Nuclear Medicine  
Date Published: 2024-06-01
Language: English
ACCESSION: WOS:001289165600093
PROVIDER: wos
Notes: Meeting Abstract: 241064 -- Source: Wos